Bunge Limited

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

Can Bunge Global Stock Hit $130? - trefis.com

Capacity expansion Financial outlook AI-generated analysis

πŸ“ˆ Bunge Global stock hit a three-year high of $130.59, trading at 16.5x earnings versus a median S&P 500 multiple of 21.8x.

🌱 Revenue reached $93.5 billion in the four quarters ended September 30, 2026, representing a 55.5% increase from the prior year.

🏭 The company combined with Viterra to align its softseeds business volume with its global soy crushing operations.

πŸ’Έ Net income fell to $1.16 billion despite revenue growth, as net margins narrowed to 1.2% and operating margins held at 2.6%.

πŸ“‰ Total debt climbed significantly to $18.3 billion, equating to 95.6% of market value compared to 19% for the S&P 500 median.

πŸ’° Free cash flow turned negative at -$2.66 billion over the trailing four quarters due to increased working capital and higher interest costs.

πŸ—οΈ Three of four major projects are active, including a Morristown, Indiana soy protein plant and a Westzaan refinery expected in Q1 2027.

πŸ’΅ Management expects new plants and savings to deliver approximately $0.50 per share in earnings for fiscal year 2027.

πŸ“Š Full-year 2026 adjusted earnings guidance remains between $9.25 and $9.75, significantly higher than reported EPS of $1.64.

πŸ” Investors are watching February 2027 earnings for confirmation that cash flow issues resolve as operational improvements take effect.

Bullish Signals
  • Bunge Global shares reached a three-year high of $130.59, indicating renewed investor interest despite valuation discounts.
  • Revenue surged 55.5% year-over-year to $93.5 billion over the four quarters ended September 30, 2026, driven by strong volume growth.
  • The strategic combination with Viterra successfully elevated softseeds business volume to parity with global soy crushing operations.
  • Operating margin improved to 3.1% in fiscal Q3 2026 from 1.7% a year earlier due to better commodity conditions and integration savings.
  • Management maintains full-year 2026 adjusted earnings guidance of $9.25 to $9.75 per share, well above reported EPS.
  • Three of four major expansion projects are currently running, including the Morristown soy protein plant and Westzaan refinery.
Risk Factors
  • Net income declined to $1.16 billion from $1.32 billion a year earlier despite massive revenue growth.
  • Net margins compressed significantly to 1.2% compared to an average of 1.9% over the latest three twelve-month periods.
  • Total debt escalated to $18.3 billion, representing 95.6% of market value versus a healthy 19% for the S&P 500 median.
  • Net interest expense rose primarily due to higher net debt levels and lower interest income in fiscal Q3 2026.
  • Free cash flow turned negative at -$2.66 billion over the trailing four quarters, indicating cash is leaving the business.
  • Working capital requirements have risen sharply, driven mostly by price fluctuations, exacerbating the cash burn.
Full Analysis
Bunge Global (BG) shares recently closed at $130.59, marking a three-year high, though the stock currently trades at a significant discount to the S&P 500 median multiple of earnings. The company has executed a major combination with Viterra, which has elevated its softseeds business to parity with its soy crushing operations globally. Revenue surged 55.5% year-over-year over the four quarters ended September 30, 2026, driven by strong volume growth in oilseed crushing and grain trading. Despite top-line expansion, Bunge's net income declined to $1.16 billion from a year earlier as operating margins compressed and thin profit margins persisted. The company faces substantial financial headwinds, including total debt climbing to $18.3 billion, which represents 95.6% of its market value compared to roughly 19% for the broader S&P 500. Consequently, free cash flow turned negative at -$2.66 billion over the trailing four quarters due to rising working capital requirements and higher interest expenses. Management projects that new capacity expansions, including a Westzaan refinery startup in early 2027, along with cost savings from the Viterra integration, will contribute approximately $0.50 per share in 2027. The stock's valuation relies on the market correcting its view of Bunge as a sound business on sale once these operational improvements and cash flow generation materialize in future reporting periods. Analysts and management are closely watching full-year 2026 adjusted earnings guidance, which stands between $9.25 and $9.75 per share, to determine if the current discount reflects a temporary cash crunch or a structural issue. The upcoming February 2027 earnings report is expected to provide critical updates on whether the company can successfully convert its revenue growth into profitable cash flow.